Search by Drug Name or NDC
NDC 00173-0388-79 BECONASE 42 ug/1 Details
BECONASE 42 ug/1
BECONASE is a NASAL SPRAY, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is BECLOMETHASONE DIPROPIONATE MONOHYDRATE.
MedlinePlus Drug Summary
Beclomethasone nasal spray is used to relieve symptoms of sneezing, runny, stuffy, or itchy nose (rhinitis) caused by hay fever, other allergies, or vasomotor (nonallergic) rhinitis. It is also used to prevent nasal polyps (swelling of the lining of the nose) after nasal polyp removal surgery. Beclomethasone nasal spray should not be used to treat symptoms (e.g., sneezing, stuffy, runny, itchy nose) caused by the common cold. Beclomethasone nasal spray is in a class of medications called corticosteroids. It works by blocking the release of certain natural substances that cause allergy symptoms.
Related Packages: 00173-0388-79Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Beclomethasone Nasal Spray
Product Information
| NDC | 00173-0388 |
|---|---|
| Product ID | 0173-0388_29265e11-dbd6-4061-96ad-17b4f239ce60 |
| Associated GPIs | 42200010321810 |
| GCN Sequence Number | 008078 |
| GCN Sequence Number Description | beclomethasone dipropionate SPRAY 42 MCG NASAL |
| HIC3 | Q7P |
| HIC3 Description | NASAL ANTI-INFLAMMATORY STEROIDS |
| GCN | 47100 |
| HICL Sequence Number | 000070 |
| HICL Sequence Number Description | BECLOMETHASONE DIPROPIONATE |
| Brand/Generic | Brand |
| Proprietary Name | BECONASE |
| Proprietary Name Suffix | AQ |
| Non-Proprietary Name | beclomethasone dipropionate monohydrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, SUSPENSION |
| Route | NASAL |
| Active Ingredient Strength | 42 |
| Active Ingredient Units | ug/1 |
| Substance Name | BECLOMETHASONE DIPROPIONATE MONOHYDRATE |
| Labeler Name | GlaxoSmithKline LLC |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019389 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0388-79 (00173038879)
| NDC Package Code | 0173-0388-79 |
|---|---|
| Billing NDC | 00173038879 |
| Package | 1 BOTTLE, PUMP in 1 CARTON (0173-0388-79) / 180 SPRAY, SUSPENSION in 1 BOTTLE, PUMP |
| Marketing Start Date | 1989-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 11.1689 |
| Pricing Unit | GM |
| Effective Date | 2023-12-20 |
| NDC Description | BECONASE AQ 0.042% SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |